Purpose: The purpose of our study was to test dynamic helical CT (hCT)
in the evaluation of breast tumors. Method: Thirty-six patients with
39 suspected lesions underwent breast hCT before and 1, 3, and 8 min a
fter intravenous contrast medium administration, A marked enhancement
(greater than or equal to 100%) at 1 or 3 min without increase at 8 mi
n was considered as the primary indicator for malignancy. Twenty carci
nomas, one metastatic non-Hodgkin lymphoma, six fibroadenomas, and six
other benign findings were histologically assessed. Six cases had neg
ative fine needle aspiration cytology and at least it 2 year negative
follow-up. Results: hCT showed a 100% sensitivity and 83.3% specificit
y. Considering carcinomas and fibroadenomas, significant differences w
ere found for the percent enhancement at 1 min (p = 0.002) as well as
for the density increase or decrease at 3 versus 1 min (p = 0.0035), a
t 8 versus 1 min (p = 0.0027), and at 8 versus 3 min (p = 0.0180). Con
clusion: hCT proved to have a high diagnostic efficacy in evaluating b
reast tumors. Even though it involves some exposure to radiation, it s
hould be considered in patients in whom MR is contraindicated.